Actavia Life Sciences Inc (RASP)
0.0016
0.00 (0.00%)
USD |
OTCM |
Jul 02, 16:00
Actavia Life Sciences Enterprise Value: 1.538M for July 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| July 02, 2024 | 1.538M |
| July 01, 2024 | 1.538M |
| June 28, 2024 | 1.538M |
| June 27, 2024 | 1.538M |
| June 26, 2024 | 1.538M |
| June 25, 2024 | 1.538M |
| June 24, 2024 | 1.538M |
| June 21, 2024 | 1.538M |
| June 20, 2024 | 7.249M |
| June 18, 2024 | 7.249M |
| June 17, 2024 | 7.249M |
| June 14, 2024 | 7.249M |
| June 13, 2024 | 7.249M |
| June 12, 2024 | 7.249M |
| June 11, 2024 | 7.249M |
| June 10, 2024 | 7.249M |
| June 07, 2024 | 7.249M |
| June 06, 2024 | 7.249M |
| June 05, 2024 | 7.249M |
| June 04, 2024 | 7.249M |
| June 03, 2024 | 9.564M |
| May 31, 2024 | 13.35M |
| May 30, 2024 | 13.35M |
| May 29, 2024 | 13.35M |
| May 28, 2024 | 13.35M |
| Date | Value |
|---|---|
| May 24, 2024 | 13.35M |
| May 23, 2024 | 13.35M |
| May 22, 2024 | 13.35M |
| May 21, 2024 | 13.35M |
| May 20, 2024 | 13.35M |
| May 17, 2024 | 13.35M |
| May 16, 2024 | 13.35M |
| May 15, 2024 | 11.42M |
| May 14, 2024 | 8.792M |
| May 13, 2024 | 8.792M |
| May 10, 2024 | 8.792M |
| May 09, 2024 | 9.950M |
| May 08, 2024 | 13.65M |
| May 07, 2024 | 13.65M |
| May 06, 2024 | 13.65M |
| May 03, 2024 | 13.65M |
| May 02, 2024 | 13.65M |
| May 01, 2024 | 13.65M |
| April 30, 2024 | 13.65M |
| April 29, 2024 | 13.65M |
| April 26, 2024 | 13.65M |
| April 25, 2024 | 6.323M |
| April 24, 2024 | 6.323M |
| April 23, 2024 | 6.323M |
| April 22, 2024 | 6.323M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.4703M
Minimum
Apr 19 2022
38.69M
Maximum
Mar 06 2023
6.288M
Average
4.861M
Median
Sep 27 2021
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.015M |
| Palatin Technologies Inc | 20.32M |
| iBio Inc | 25.20M |
| Theriva Biologics Inc | -11.33M |
| Oragenics Inc | 4.218M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.0955M |
| Total Expenses (Quarterly) | 0.0714M |
| EPS Diluted (Quarterly) | -0.0001 |
| Earnings Yield | -120.0% |